受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
Synonyms | (R)-(+)-WIN 55212 | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|
化学式 | C28H30N2O6S |
|||
分子量 | 522.61 | CAS No. | 131543-23-2 | |
Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (191.34 mM) | |
Ethanol | 20 mg/mL (38.26 mM) | |||
Water | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
製品説明 | WIN 55,212-2 Mesylate ((R)-(+)-WIN 55212) is a potent cannabinoid (CB) receptor agonist with Ki of 3.3 nM and 62.3 nM for human recombinant CB2 and CB1, respectively. WIN 55,212-2 Mesylate regulates Glutamate transmission. | |||||
---|---|---|---|---|---|---|
in vitro | WIN 55,212-2 increases, in a nanomolar concentration range, extra-cellular glutamate levels in primary cultures of rat cerebral cortex neurons, displaying a bell-shaped concentration-response curve.[1] The aminoalkylindole WIN 55,212-2 is more selective for the CB2 than the CB1 receptor, with a CB2-to-CB1 dose-response ratio of 19.[2] |
|||||
in vivo | The result provide in vivo evidence for CB1 receptor-mediated increase on endogenous glutamate levels in the cerebral cortex. The cannabinoid receptor agonist WIN 55,212-2, at low mg/kg doses, enhances dialysate glutamate levels in the prefrontal cortex of the awake rat.[1] |
|||||
密度 | g/mL |
細胞アッセイ | 細胞株 | cerebral cortical cells |
---|---|---|
濃度 | 1 nM, 10 nM | |
反応時間 | 15 min | |
実験の流れ | On the day of the release experiment, the cells are rinsed twice by replacing the culture medium with Krebs Ringer-bicarbonate buffer (37℃). Thereafter, five consecutive fractions are collected, renewing this solution (400μl) every 30 min. The first 2 samples are used to assess basal glutamate levels, while pharmacological treatments are carried out during the third fraction. WIN 55,212-2 is applied 15 min before the end of the third fraction. |
|
動物実験 | 動物モデル | male adult sprague-dawley rats |
投薬量 | 0.01 mg/kg - 2 mg/kg | |
投与方法 | IP |
|
Gut-microbiota-brain axis in the vulnerability to psychosis in adulthood after repeated cannabis exposure during adolescence [ Eur Arch Psychiatry Clin Neurosci, 2022, 10.1007/s00406-022-01437-1] | PubMed: 35666299 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。